Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s46, 2020. DOI: 10.25251/skin.4.supp.46. Disponível em: https://skin.dermsquared.com/skin/article/view/995. Acesso em: 8 jun. 2025.